WS #13277
Holding: newest synthesis is 111d 11h old
AZN and BMY reportedly in talks for $400B merger, with market skepticism on value creation.
AstraZeneca-BMS merger
AZN and BMY reportedly in talks for $400B merger, with market skepticism on value creation.